Get the Stockscreener App
29.81
1.26%
0.37
Pre-market:
29.81
Assembly Biosciences Inc stock is traded at $29.81, with a volume of 62,139.
It is up +1.26% in the last 24 hours and up +6.03% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
See More
Previous Close:
$29.44
Open:
$29.42
24h Volume:
62,139
Relative Volume:
0.66
Market Cap:
$472.87M
Revenue:
$72.30M
Net Income/Loss:
$-6.12M
P/E Ratio:
-16.22
EPS:
-1.8384
Net Cash Flow:
$-41.16M
1W Performance:
+1.57%
1M Performance:
+6.03%
6M Performance:
+4.82%
1Y Performance:
+203.87%
1-Day Range:
$29.28
$30.05
1-Week Range:
$28.26
$30.72
52-Week Range:
$9.68
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
29.81 | 467.00M | 72.30M | -6.12M | -41.16M | -1.8384 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
Responsive Playbooks and the ASMB Inflection - Stock Traders Daily
EV Market: Is Assembly Biosciences Inc exposed to currency risks2026 Levels & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
ASMB Options Volatility — NASDAQ:ASMB - TradingView — Track All Markets
ASMB Options Chain — NASDAQ:ASMB - TradingView — Track All Markets
Weekly Earnings: Should I set a stop loss on Assembly Biosciences Inc2026 Intraday Action & Stock Portfolio Risk Control - baoquankhu1.vn
Sentiment Review: Is Assembly Biosciences Inc being accumulated by smart moneyQuarterly Investment Review & AI Driven Stock Reports - baoquankhu1.vn
ASMB Stock Price, Quote & Chart | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 - Bitget
Assembly Bio's herpes drug studies win oral and late-breaker slots - Stock Titan
Treasury Yields: Will Assembly Biosciences Inc outperform during market ralliesWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
Assembly Biosciences (ASMB) Gets a Buy from Guggenheim - The Globe and Mail
Fundamentals Check: Is Assembly Biosciences Inc stock showing strong momentumWeekly Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Downgrade Watch: What is the target price for Assembly Biosciences Inc stock2026 Market Outlook & Consistent Profit Trade Alerts - baoquankhu1.vn
Options Flow: Is Assembly Biosciences Inc benefiting from innovation trends2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn
Guggenheim Raises Price Target for ASMB to $43, Maintains Buy Ra - GuruFocus
Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim - MarketBeat
Guggenheim raises Assembly Biosciences stock price target on herpes drug progress - Investing.com Canada
Understanding the Setup: (ASMB) and Scalable Risk - Stock Traders Daily
Bull Bear: What is the target price for Assembly Biosciences Inc stock2026 Retail Activity & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Assembly Biosciences CMO White sells $5.3k in stock By Investing.com - Investing.com Canada
Assembly Biosciences PFO Bjorkquist sells $8.7k in shares By Investing.com - Investing.com Australia
[Form 4] ASSEMBLY BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) officer logs RSU grant, tax sell-to-cover - Stock Titan
Assembly Biosciences (ASMB) officer awarded RSUs and sells shares to cover taxes - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 26,000 RSUs vesting through 2030 - stocktitan.net
Assembly Biosciences (ASMB) CEO receives 94,250 RSUs vesting through 2030 - Stock Titan
Resistance Check: Is Assembly Biosciences Inc benefiting from innovation trends2026 WrapUp & Consistent Profit Trade Alerts - baoquankhu1.vn
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan - tipranks.com
Assembly Biosciences (ASMB) boosts CEO bonus target in 2026 plan - Stock Titan
HC Wainwright Analysts Lower Earnings Estimates for ASMB - Defense World
[EFFECT] ASSEMBLY BIOSCIENCES, INC. SEC Filing - Stock Titan
Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy - MarketBeat
ETF Watch: Is Assembly Biosciences Inc benefiting from innovation trends2026 Chart Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
Q1 Earnings Estimate for ASMB Issued By HC Wainwright - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright - MarketBeat
Analyst Patrick R. Trucchio Reiterates Buy Rating for ASMB | ASM - GuruFocus
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences Inc (V7B.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):